Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Donald R. Branch:

Search results

Items: 1 to 20 of 98

1.

IgG3 anti-Kell allotypic variation results in differential antigen binding and phagocytosis.

Cen SY, Holton MB, Binnington B, Denomme GA, Howie HL, Lebedev JN, Zimring JC, Branch DR.

Transfusion. 2020 Jan 13. doi: 10.1111/trf.15663. [Epub ahead of print]

PMID:
31930726
3.

Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer.

Lewis BJB, Ville J, Blacquiere M, Cen S, Spirig R, Zuercher AW, Käsermann F, Branch DR.

BMC Immunol. 2019 Dec 4;20(1):44. doi: 10.1186/s12865-019-0328-6.

4.

Human red blood cell stroma: an alternative to traditional allogeneic adsorption methods.

Wilson EM, Branch DR.

Transfusion. 2019 Dec;59(12):3736-3745. doi: 10.1111/trf.15585. Epub 2019 Nov 11.

PMID:
31710381
5.

Targeting ABL1 or ARG Tyrosine Kinases to Restrict HIV-1 Infection in Primary CD4+ T-Cells or in Humanized NSG Mice.

McCarthy SDS, Leontyev D, Nicoletti P, Binnington B, Kozlowski HN, Ostrowski M, Cochrane A, Branch DR, Wong RW.

J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):407-415. doi: 10.1097/QAI.0000000000002144.

PMID:
31658184
6.

Eluates from DAT-positive patients with or without hemolysis after high-dose IVIG yield predominantly IgG isoagglutinins of IgG2 subclass.

Yung GP, Seebach JD, Baerenzung N, Pendergrast J, Cserti-Gazdewich C, Branch DR.

Transfusion. 2019 May;59(5):1882-1883. doi: 10.1111/trf.15229. No abstract available.

PMID:
31050825
7.

A GYPB variant encoding an altered leader peptide leads to a weak S phenotype.

Cote J, Cen S, Fennell K, Pambrun C, Branch DR, Ochoa-Garay G.

Transfusion. 2019 Jul;59(7):2461-2462. doi: 10.1111/trf.15295. Epub 2019 Mar 30. No abstract available.

PMID:
30927367
8.
9.

Immunotherapy: the good, the bad, the ugly, and the really ugly.

Branch DR.

Transfusion. 2019 Feb;59(2):437-440. doi: 10.1111/trf.15142. No abstract available.

PMID:
30727039
10.

The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2.

Lemay AS, Tong TN, Branch DR, Huang M, Sumner C, Oldfield L, Hawes J, Cserti-Gazdewich CM, Lau W.

Transfusion. 2018 Nov;58(11):2506-2512. doi: 10.1111/trf.14867. Epub 2018 Oct 9.

PMID:
30299537
11.

The Monocyte Monolayer Assay: Past, Present and Future.

Tong TN, Cen S, Branch DR.

Transfus Med Rev. 2019 Jan;33(1):24-28. doi: 10.1016/j.tmrv.2018.07.004. Epub 2018 Aug 8. Review.

PMID:
30139679
12.

GPIbα is required for platelet-mediated hepatic thrombopoietin generation.

Xu M, Li J, Neves MAD, Zhu G, Carrim N, Yu R, Gupta S, Marshall J, Rotstein O, Peng J, Hou M, Kunishima S, Ware J, Branch DR, Lazarus AH, Ruggeri ZM, Freedman J, Ni H.

Blood. 2018 Aug 9;132(6):622-634. doi: 10.1182/blood-2017-12-820779. Epub 2018 May 24.

PMID:
29794068
13.

Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay.

Kipkeu BJ, Shyian ML, da Silveira Cavalcante L, Duong TT, Yeung RSM, Binnington B, Branch DR, Acker JP, Holovati JL.

Transfusion. 2018 Aug;58(8):2027-2035. doi: 10.1111/trf.14650. Epub 2018 May 9.

PMID:
29744883
14.

Red blood cells, still vital after all these years: Commentary on Canadian Blood Services' International Symposium 2017.

Qadri SM, Donkor DA, Yan M, Ning S, Branch DR, Seghatchian J, Sheffield WP.

Transfus Apher Sci. 2018 Apr;57(2):298-303. doi: 10.1016/j.transci.2018.04.011. Epub 2018 Apr 19. Review.

PMID:
29691151
15.

rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.

Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Käsermann F, Zuercher AW.

J Immunol. 2018 Apr 15;200(8):2542-2553. doi: 10.4049/jimmunol.1701171. Epub 2018 Mar 12.

16.

Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure.

Qadri SM, Donkor DA, Nazy I, Branch DR, Sheffield WP.

Eur J Haematol. 2018 May;100(5):502-510. doi: 10.1111/ejh.13047. Epub 2018 Mar 30.

PMID:
29453885
17.

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.

Branch DR, Hellberg Å, Bruggeman CW, Storry JR, Sakac D, Blacquiere M, Tong TN, Burke-Murphy E, Binnington B, Parmar N, Riden LS, Willie K, Armali C, Aziz J, Lieberman L, Laroche V, Callum J, Lin Y, Shehata N, Pavenski K, Lau W, Hannach B, Kuijpers TW, Olsson ML, Cserti-Gazdewich C, Pendergrast J.

Blood. 2018 Feb 15;131(7):830-835. doi: 10.1182/blood-2017-07-796151. Epub 2018 Jan 5. No abstract available.

PMID:
29305554
18.

IVIG regulates the survival of human but not mouse neutrophils.

Schneider C, Wicki S, Graeter S, Timcheva TM, Keller CW, Quast I, Leontyev D, Djoumerska-Alexieva IK, Käsermann F, Jakob SM, Dimitrova PA, Branch DR, Cummings RD, Lünemann JD, Kaufmann T, Simon HU, von Gunten S.

Sci Rep. 2017 May 2;7(1):1296. doi: 10.1038/s41598-017-01404-0.

19.

The immune-stimulation capacity of liposome-treated red blood cells.

da Silveira Cavalcante L, Branch DR, Duong TT, Yeung RSM, Acker JP, Holovati JL.

J Liposome Res. 2018 Sep;28(3):173-181. doi: 10.1080/08982104.2017.1295991. Epub 2017 Mar 9.

PMID:
28276279
20.

Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis.

Tong TN, Branch DR.

J Vis Exp. 2017 Jan 2;(119). doi: 10.3791/55039.

Supplemental Content

Loading ...
Support Center